These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 16857269
1. Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation. Ubogu EE, Callahan MK, Tucky BH, Ransohoff RM. J Neuroimmunol; 2006 Oct; 179(1-2):132-44. PubMed ID: 16857269 [Abstract] [Full Text] [Related]
2. Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. Weiss JM, Downie SA, Lyman WD, Berman JW. J Immunol; 1998 Dec 15; 161(12):6896-903. PubMed ID: 9862722 [Abstract] [Full Text] [Related]
3. The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density. Desmetz C, Lin YL, Mettling C, Portalès P, Rabesandratana H, Clot J, Corbeau P. Immunology; 2006 Dec 15; 119(4):551-61. PubMed ID: 17177831 [Abstract] [Full Text] [Related]
5. Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1. Prat A, Biernacki K, Antel JP. J Autoimmun; 2005 Mar 15; 24(2):119-24. PubMed ID: 15829404 [Abstract] [Full Text] [Related]
6. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis. Ifergan I, Wosik K, Cayrol R, Kébir H, Auger C, Bernard M, Bouthillier A, Moumdjian R, Duquette P, Prat A. Ann Neurol; 2006 Jul 15; 60(1):45-55. PubMed ID: 16729291 [Abstract] [Full Text] [Related]
7. Adhesion and migration of polymorphonuclear leukocytes across human brain microvessel endothelial cells are differentially regulated by endothelial cell adhesion molecules and modulate monolayer permeability. Wong D, Prameya R, Dorovini-Zis K. J Neuroimmunol; 2007 Mar 15; 184(1-2):136-48. PubMed ID: 17291598 [Abstract] [Full Text] [Related]
8. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis. Krakauer M, Sorensen PS, Khademi M, Olsson T, Sellebjerg F. Scand J Immunol; 2006 Aug 15; 64(2):155-63. PubMed ID: 16867161 [Abstract] [Full Text] [Related]
9. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration. Abu Nabah YN, Losada M, Estellés R, Mateo T, Company C, Piqueras L, Lopez-Gines C, Sarau H, Cortijo J, Morcillo EJ, Jose PJ, Sanz MJ. Arterioscler Thromb Vasc Biol; 2007 Nov 15; 27(11):2370-6. PubMed ID: 17717298 [Abstract] [Full Text] [Related]
18. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting. Correale J, Villa A. Autoimmunity; 2007 Mar 15; 40(2):148-60. PubMed ID: 17453713 [Abstract] [Full Text] [Related]
19. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine. Kang SG, Piniecki RJ, Hogenesch H, Lim HW, Wiebke E, Braun SE, Matsumoto S, Kim CH. Gastroenterology; 2007 Mar 15; 132(3):966-81. PubMed ID: 17324406 [Abstract] [Full Text] [Related]